Schizophrenia Clinical Trials

Showing 1121-1140 of 1,172 trials

Treating Psychotic Symptoms of Young Individuals Presenting a First Episode of Schizophrenia: Comparison of Two State-of-the-Art Interventions

NCT00358709

To verify the efficacy of a group cognitive-behavioral therapy approach to lessening psychotic symptoms of individuals with a first episode of psychosis, and to compare its effects to a known skills training approach and a control group. Our primary hypotheses were that CBT would do better than the control group at all points in time, and better than the skills training approach, though only at follow-ups

Schizophrenia

University of British Columbia129 participantsStarted Jun 2002

Surrey, British Columbia, Canada

TERMINATEDPhase 3

Compare the Effects of Bifeprunox and Quetiapine on Weight Changes in Stable Schizophrenic Patients

NCT00396214

The primary objective of the study is to evaluate changes in weight short and long term with bifeprunox and quetiapine. Study participation for the subject is 57 weeks.

Schizophrenia

Solvay Pharmaceuticals83 participantsStarted Apr 2007

Anaheim, California, United States • Anaheim, California, United States • Cerritos, California, United States +148 more locations

Treating Psychotic Symptoms of Young Individuals Presenting a First Episode of Schizophrenia: Comparison of Two State-of-the-Art Interventions

Compare the Effects of Bifeprunox and Quetiapine on Weight Changes in Stable Schizophrenic Patients

Related Searches

Clozapine-Augmentation With Ziprasidone or Risperidone, a Randomized, Prospective Trial

Switch Study of Existing Atypical Antipsychotics to Bifeprunox

Guanfacine Adjunctive Treatment to Atypical Antipsychotics for Cognitive Dysfunction in Schizophrenia

Digital Voice Analysis in Patients With Schizophrenia

Dopaminergic Neurotransmission in Schizophrenia, Patients at Risk and Healthy Subjects

Extract of Ginkgo Biloba and Tardive Dyskinesia

Cognitive Determinants of Psychoeducation and Information in Psychoses

Bifeprunox in the Treatment of Schizophrenia

Evaluation of the Antipsychotic Efficacy of Cannabidiol in Acute Schizophrenic Psychosis

β-Cell Function in Schizophrenic Subjects on Atypical Antipsychotic drugS

Neuropsychiatric Evaluation of Healthy Volunteers and Adults With Schizophrenia

Treatment of Childhood Onset Psychiatric Disorders With Intravenous Immunoglobulin (IVIg)

Genetic Aspects of Neurologic and Psychiatric Disorders

Imaging of Brain Receptors in Healthy Volunteers and in Patients With Schizophrenia

Glycine to Treat Psychotic Disorders in Children

Neuroimaging of Dopamine Metabolism in Normal and Psychiatric Patients

Repetitive Transcranial Magnetic Stimulation

Prodrome-Based Early Intervention With Antipsychotics vs. Benzodiazepines in First-Episode Schizophrenia